论文部分内容阅读
目的探讨并总结糖尿病合并冠状动脉性心脏病患者的治疗方法和临床疗效,进一步寻求更好的治疗方法。方法选取2009年8月至2012年8月在我院治疗的糖尿病合并冠状动脉性心脏病患者90例,随机分为实验组和对照组,每组45例,实验组采用阿托伐他汀联合苯那普利进行治疗,对照组采用阿托伐他汀治疗,对比两组患者治疗1年后的甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(HbA1c)、ST段下降次数及尿白蛋白。结果实验组患者的血糖和血脂控制更佳,尿白蛋白排泄显著减少,心血管事件发生率明显降低,差异具统计学意义。结论阿托伐他汀联合苯那普利治疗糖尿病合并冠状动脉性心脏病患者的临床效果好,心血管事件的发生率低,有很好的临床意义和推广价值。
Objective To explore and summarize the treatment and clinical efficacy of diabetes mellitus patients with coronary heart disease and to seek better treatment methods. Methods 90 patients with diabetes mellitus and coronary heart disease who were treated in our hospital from August 2009 to August 2012 were randomly divided into experimental group and control group with 45 cases in each group. The experimental group was treated with atorvastatin combined with benzene Patients in the control group were treated with atorvastatin. The levels of triglyceride (TG), low density lipoprotein cholesterol (LDL-C), glycosylated hemoglobin (HbA1c), ST segment Declines and urinary albumin. Results The experimental group had better control of blood glucose and blood lipids, significantly reduced urinary albumin excretion, and significantly reduced the incidence of cardiovascular events. The difference was statistically significant. Conclusion Atorvastatin combined with benazepril in the treatment of diabetic patients with coronary heart disease has a good clinical effect, the incidence of cardiovascular events is low, and has good clinical significance and promotion value.